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Abstract
Objective: In primary aldosteronism, adrenal venous sampling (AVS) is essential for subtype
differentiation as it evaluates aldosterone secretion from both adrenals. Selectivityof adrenal sampling
is assessed by the ratio of cortisol concentrations in adrenal venous blood and inferior vena cava blood
(Cadrenal/Civc). Since the criteria for selective adrenal sampling differ among the reported literature, we
performed a study to evaluate the inﬂuence of different selectivity criteria on AVS results.
Design and methods: Reports of AVS were screened retrospectively. All AVS were performed with
cosyntrophin infusion. Reports containing samples with Cadrenal/CivcR10 taken from both adrenals
and at least one other adrenal sample characterised by Cadrenal/CivcR1.1 were enrolled. For each
individual, we chose reference samples that were deﬁned by the highest Cadrenal/Civc achieved from
each adrenal. The signiﬁcance of the remaining samples with Cadrenal/CivcR1.1 was analysed in regard
to their respective reference samples. We assessed the impact of analysed samples on identiﬁcation of
lateralisation of aldosterone secretion that is crucial for decisions concerning adrenalectomy.
Results: AVSreportsof87patientswereenrolled.Atotalof225adrenalsampleswereanalysedanddivided
into ﬁve groups according to Cadrenal/Civc:1.1–1.99, 2–2.99, 3–4.99, 5–9.99 and R10. By comparing
reference with analysed samples, a concordant assessment with respect to lateralisation of aldosterone
secretion was observed in 39, 52, 72, 85 and 94% of the respective groups of analysed samples.
Conclusion: AVSprovides consistentinformation whenadrenalsampleswith high cortisolconcentrations
are used.
European Journal of Endocrinology 162 101–107
Introduction
Primary aldosteronism represents a frequent and poten-
tially curable form of secondary arterial hypertension.
Provided there is unilateral aldosterone overproduction,
adrenalectomy leads to improvement or even normal-
isation of elevated blood pressure in the majority of
patients (1, 2). The only diagnostic method that can, in
principle, differentiate between unilateral and bilateral
aldosterone hypersecretion is adrenal venous sampling
(AVS),withsamples takenfrombothadrenal veins(3, 4).
The success rate of the AVS procedure depends on an
accurate cannulation of both adrenal veins. Since a high
cortisol concentration is an explicit determinant of the
adrenal venous blood, the adequacy of AVS is usually
evaluatedbytheratioofthecortisolconcentrationsinthe
adrenal vein and in the inferior vena cava (Cadrenal/Civc).
High Cadrenal/Civc is a result of less dilute blood from the
adrenal veins, which is a more representative sample of
the adrenal venous blood.
As the production of cortisol by both adrenals is
considered symmetrical, cortisol-corrected aldosterone
concentrations (ACs) are used to compare aldosterone
production from both adrenals. The aldosterone-
to-cortisol concentration ratio (AC) is intended to
eliminate the variable dilution effect when adrenal
samples are taken. The lateralisation of aldosterone
secretion is measured by the ratio of the ACs from both
the adrenals (ACR), and is deﬁned as ACdominant
adrenal/ACnon-dominant adrenal.
The arbitrary criteria for interpreting AVS data
differ greatly among the published literature (5–10).
The current guidelines for adrenal sampling deﬁne the
adrenal/peripheral vein cortisol ratio as typically
O10:1 with the continuous infusion of cosyntrophin,
and more than 3:1 without cosyntrophin (11). The
published criteria for appropriate adrenal vein sampling
range from Cadrenal/CivcR2 – 5w i t hc o s y n t r o p h i n
(12, 13) and from Cadrenal/CivcR1.1–3 without cosyn-
trophin (14, 15).
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success rate of the AVS procedure; however, this
approach carries a potential risk of misleading AVS
results due to excessive dilution of the adrenal venous
blood. On the other hand, a higher Cadrenal/Civc cut-off
increases the number of patients with unsuccessful AVS.
It is evident that, among patients with unsuccessful
AVS, there must be a signiﬁcant portion of those for
whom adrenalectomy is inappropriately denied.
We evaluated the accuracy of various Cadrenal/Civc
cut-offs that are used to identify representative adrenal
samples as an indication for adrenal surgery.
Subjects and methods
The AVS protocols of patients who underwent successful
adrenal catheterisation were screened retrospectively.
The included reports contained samples with Cadrenal/
CivcR10 taken from both adrenals, and at least one
other sample with Cadrenal/CivcR1.1.
Indication of AVS resulted from a high clinical
suspicion of primary aldosteronism, which was based
on a previous non-invasive diagnostic work-up. With-
drawal of aldosterone antagonists for 2 months was
required before the procedures were initiated. The
aldosterone-to-active renin concentration ratio (ARR)
was used to screen patients for primary aldosteronism.
Blood sampling for ARR was always performed in the
morning hours (0700–1000 h) with the patients in
the upright position for at least 30 min before sample
collection. For calculation of ARR, both serum aldos-
terone and plasma renin concentrations were expressed
in ng/l. ARRO20 was considered to be an abnormal
value, which was the cut-off value based upon our
observations in 69 healthy volunteers (M Solar, J Ceral
and E Malirova, unpublished data). Before sampling for
ARR, no speciﬁc changes in antihypertensive medi-
cation were initially required (except for the withdrawal
of any aldosterone antagonists as mentioned above).
However, if the patient presented with an ARRO20,
adrenal adenoma or hypokalaemia, ARR sampling was
repeated after 2 weeks of withdrawal from any
medication that could interfere with the renin–
angiotensin–aldosterone system. Only doxazosin and
verapamil were allowed for patients who were
considered at risk from uncontrolled hypertension.
Based on persistent elevation of ARR (O20), the
patients were referred for suppression testing.
Verapamil and doxazosin were the only antihyper-
tensive drugs allowed. Blood samples for serum
aldosterone were taken in the supine position after a
4 h saline infusion (2000 ml) and a previous period of
high salt intake. Aldosterone was considered non-
suppressible when it was O100 pmol/l, which was
the cut-off value based on our observations from 32
healthy volunteers (M Solar, J Ceral and E Malirova,
unpublished data).
All AVS procedures were performed according to the
routine standardised protocol used in our centre. No
changes in concomitant medications were required,
except for oral anticoagulants and aldosterone antagon-
ists that had to be withdrawn before the procedure. All
of the patients were given informed written consent for
the AVS procedure according to the following protocol.
In order to minimise stress-induced ﬂuctuations in
secretion of adrenal hormones, an infusion of cosyn-
trophin was administered 30 min before and during the
procedure at a rate of 160 mg/h. The design of the
cosyntrophin dosing scheme was inspired by previous
reports (3, 4). Samples were taken step by step from
both adrenal veins, one of the hepatic veins, and the
inferior vena cava below the renal veins. Hepatic and
inferior vena cava samples served as controls, which
helped us to obviate the origin of all samples collected.
Because the cannulation of the adrenal veins
(especially the right adrenal vein) is technically difﬁcult,
multiple samples were taken in order to increase the
success rate of the procedure.
Angiographic veriﬁcation of the catheter placement
into the adrenal veins was required both before and
immediately after sampling in order to exclude the
possibility of catheter displacement during blood
sampling. Small amounts of a contrast agent were
used to diminish the risk of adrenal injury.
In order to minimise uncertainties when referring the
patients for adrenalectomy, we adopted the strict criteria
published by Young et al. (13). The AVS procedure was
considered successful when samples with Cadrenal/Civc-
R5 were obtained from both adrenals. Abnormal
lateralisation of aldosterone secretion was then deﬁned
by ACRO4.
A reference sample for each adrenal was chosen from
each patient included in our study. The reference
s a m p l e sw e r ed e ﬁ n e da st h eh i g h e s tCadrenal/Civc
achieved from a given adrenal. The remaining adrenal
samples with Cadrenal/CivcR1.1 were subjected to
analysis.
Based on the concentrations of aldosterone and
cortisol in the reference samples, ACsreference and
ACRsreference were calculated for each individual. The
concentrations of aldosterone and cortisol from the
analysed samples were used to calculate the ACsanalysed
and ACRsanalysed. The ACRsanalysed were calculated from
the ACsanalysed and contralateral ACsreference.
Analysed samples were divided into ﬁve groups
according to the Cadrenal/Civc levels:1.1–1.99, 2–2.99,
3–4.99, 5–9.99, and R10. In each group of analysed
samples, the ACsanalysed were correlated with the
corresponding ACreference (i.e. from the same adrenal).
The comparison of ACRsanalysed and respective
ACRsreference was used to assess the impact of analysed
samples on the interpretation of the AVS results.
In order to offer applicable information for centres
using different ACR cut-offs (5, 10), we tested the impact
of different ACR cut-offs on the agreement between the
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abnormal lateralisation of aldosterone secretion.
Aldosterone and cortisol concentrations were
measured from all of the acquired samples. Commer-
cially available RIA kits were used to measure
aldosterone (Diagnostic Products Corporation, Los
Angeles, CA, USA) and cortisol (Immunotech, Beckman
Coulter, Marseille, France). In the long term, we
observed the intra-assay coefﬁcients of variation (CV)
to be !7% for the measurements of aldosterone and not
more than 5% for the measurements of cortisol. The
cross-reactivity of the diagnostic antibodies for other
steroids is low.
MedCalc (version 9, Mariakerke, Belgium) software
was used for statistical analysis of the acquired data.
Results
Between May 2005 and November 2008, 116 patients
underwent AVS in our centre. The procedure was
successful in 106 (91.3%) of these patients. Adrenal
haemorrhage occurred in one patient. This adverse
event resolved without a negative sequel. No other
complications were noted.
The AVS protocols of 87 patients who fulﬁlled the
entry criteria were enrolled in the study. The principle
characteristics of the study group are summarised in
Table 1. Lateralisation of aldosterone secretion, accor-
ding to the above-mentioned criteria, was found in 25
(29%) of the study patients. A total of 225 adrenal
samples were subjected to the analysis. The analysed
samples were divided into ﬁve groups according to the
C/Civc, as shown in Table 2.
Correlation of analysed and reference samples
Cortisol-corrected ACs from the analysed samples were
compared with their respective reference samples. No
correlation (rZ0.05) was noted in the analysed samples
with Cadrenal/Civc1.1–1.99. Weak correlations were
Table 1 Principal characteristics of the study population.
Total number of patients (number of women) 87 (22)
Age (years) 51.5 (G11.2)
Systolic blood pressure (mmHg)
a 143 (G20)
Diastolic blood pressure (mmHg)
a 84 (G15)
Number of antihypertensive drugs
a 3.9 (G1.4)
Number of patients with abnormal
CT or MR adrenal ﬁnding
b
41 (47.1%)
Serum aldosterone (pmol/l)
c 250 (G160)
Plasma active renin (ng/l)
c 2.0 (G1.6)
aDescribes the data obtained before the screening tests were done.
bDenotes a ﬁnding of adenomas, nodularity or marked asymmetry in the size
of adrenal glands.
cAfter suppression performed by 2000 ml saline infusion given during 4 h with
a previous high oral salt intake. Values are expressed as the number of
patients or mean (GS.D).
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www.eje-online.orgobserved in samples with Cadrenal/Civc2–2.99 (rZ0.37)
and Cadrenal/Civc3–4.99 (rZ0.32). Much higher corre-
lations were exhibited from the analysed samples
with Cadrenal/Civc5–9.99 (rZ0.88) and Cadrenal/CivcR10
(rZ0.90).
Comparison of analysed and reference samples
– clinical impact
Comparisons of both the analysed and reference
samples that were used in the identiﬁcation of
lateralisation of aldosterone secretion (deﬁned as
ACRO4) are shown in Table 3. The analysed samples
with Cadrenal/Civc!5 had a low to moderate agreement
with the reference samples. The samples with Cadrenal/
Civc1.1–1.99, 2–2.99 and 3–4.99 showed concordant
assessments in 39, 52 and 72% of cases with respect to
the presence or absence of lateralisation of aldosterone
secretion.
The analysed samples with Cadrenal/Civc5–9.99 and
Cadrenal/CivcR10 demonstrated the agreement with the
reference samples in 85 and 94% of cases respectively.
Table 4 shows the detailed data of the analysed samples
with Cadrenal/CivcR5, which led to the discordant
assessment in the identiﬁcation of lateralisation of
aldosterone secretion when compared with their
reference samples.
The agreement between the analysed and reference
samples was not changed when the ACR cut-off was
changed to O3a n dO5, as shown in Table 5.
Implementing the suppression of the contralateral
adrenal gland (ACnon-dominant adrenal!ACivc)i nt h e
deﬁnition of lateralisation of aldosterone secretion did
not inﬂuence the level of agreement.
Discussion
Our study has conﬁrmed that the relative cortisol
concentration of adrenal samples signiﬁcantly impacts
the interpretation of AVS data. As expected, the best
results were observed from samples with Cadrenal/Civc-
R10; however, even in this group of samples, the
agreement in the identiﬁcation of lateralisation of
aldosterone secretion was not absolute. Therefore,
clinicians can never be completely free of doubt when
deciding about adrenalectomy, even when using
samples with Cadrenal/CivcR10 for the interpretation of
AVS data.
Despite this limitation, AVS based on samples with
Cadrenal/CivcR10 can be considered as the best approach
(gold standard) for the preoperative identiﬁcation of
patients with excessive unilateral aldosterone. We do
not suppose that samples with even higher Cadrenal/Civc
are characterised by a better agreement, as suggested in
Table 4 (samples 8–11).
Although adrenal samples with Cadrenal/Civc5–9.99
might have a slightly higher risk of erroneous decisions
about adrenalectomy, we still consider these acceptable
from a clinical point of view.
Table 3 The comparison of analysed and reference samples in the detection of abnormal lateralisation of aldosterone secretion.
Analysed samples
Cadrenal/Civc1.1–
1.99 (nZ44)
Cadrenal/Civc2–2.99
(nZ25)
Cadrenal/Civc3–4.99
(nZ25)
Cadrenal/Civc5–9.99
(nZ20)
Cadrenal/CivcR10
(nZ111)
Concordant assessment
compared to reference
samples
17 (39%) 13 (52%) 18 (72%) 17 (85%) 104 (94%)
Lateralisation of aldosterone
secretion (from the left
adrenal)
5 (3) 7 (5) 3 (2) 12 (5) 42 (18)
Bilateral secretion of
aldosterone from
both adrenals
12 6 15 5 62
Discordant assessment
compared to reference
samples
27 (61%) 12 (48%) 7 (28%) 3 (15%) 7 (6%)
Unrecognised lateralisation
of aldosterone secretion
(from the left adrenal)
11 (7) 4 (1) 2 (2) 2 (2) 6 (4)
False lateralisation of
aldosterone secretion (from
the left adrenal)
15 (15) 7 (6) 5 (4) 1 (1) 1 (0)
Side interchange (false
lateralisation of aldosterone
secretion from the left
adrenal)
1100 0
Values are expressed as the number of samples (and percentages). Cadrenal/Civc represents the ratio of cortisol concentrations in the adrenal vein and in the
inferior vena cava. n denotes the number of analysed samples.
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3–4.99, we observed only moderate agreement with
their reference samples. Moreover, this group of samples
exhibited a low correlation of cortisol-corrected ACs
when compared with the reference samples. If the
samples with Cadrenal/Civc3–4.99 had been used for the
interpretation of AVS data, this would have resulted in a
high number of inappropriately performed adrenalec-
tomies (Table 3). Therefore, we cannot accept these
samples for clinical decision making. We can only
speculate whether a subgroup characterised by
Cadrenal/Civc4–4.99 would have led to a better agree-
ment. Unfortunately, our data contained only a
small number of these samples, and did not enable us
to perform a more precise analysis. The samples with
low relative cortisol concentrations (Cadrenal/Civc!3) do
not represent the secretion of the evaluated adrenal
glands. The agreement with the respective reference
samples was low, and the side interchange in the
identiﬁcation of lateralisation of aldosterone secretion
was noted.
There are several factors that may explain the
discordant results between the analysed and reference
samples. First, excessive dilution of adrenal venous
blood resulting from improper adrenal sampling,
principally, may have inﬂuenced the hormonal concen-
trations in a signiﬁcant number of analysed samples.
Actually, 96% of the analysed samples with Cadrenal/
Civc1.1–4.99 were taken from the right adrenal veins,
which are more difﬁcult to cannulate (16).T h i s
argument supports the fact that the analysed samples
with Cadrenal/Civc1.1–4.99 frequently falsely ‘shifted’ the
aldosterone secretion towards the left adrenal gland, as
demonstrated in Table 3.
Secondly, the inherent impreciseness of laboratory
estimations of hormonal concentrations may have
contributed to the observed discrepancies in samples
with both low and high relative cortisol concen-
trations. The precision of laboratory tests describes a
CV that is deﬁned by the ratio of the S.D. to the mean.
According to these statistics, 68.3% of values
measured from one sample are within the range of
one S.D. from the mean. CVs of 5% for cortisol and 7%
for aldosterone mean that 31.7% of the measured
values from one sample lie more than G5 and G7%
away from the mean. Consequently, it is likely that the
estimated cortisol concentrations in two non-adrenal
samples could differ by more than 10%. This fact
Table 4 Analysed samples with Cadrenal/CivcR5 that led to discrepancies between the ACRanalysed and the ACRreference.
Analysed samples
Ipsilateral reference
samples
Contralateral reference
samples
Lateralisation of
aldosterone secretion
Side Cadrenal/Civc AC Cadrenal/Civc AC Cadrenal/Civc AC ACRanalysed ACRreference
1 R 6.19 1.27 23.71 4.21 29.90 6.37 5.03 1.51
2 R 8.50 2.18 72.50 3.41 70.00 9.29 4.27 2.72
3 R 9.55 6.08 15.45 6.73 19.09 1.57 3.87 4.28
4 R 14.77 3.69 20.45 2.56 10.23 10.44 1.14 4.09
5 R 15.66 3.16 18.07 2.66 19.28 11.27 3.56 4.24
6 R 16.67 2.69 17.95 1.07 42.31 12.00 4.46 11.20
7 R 17.05 3.93 20.45 2.56 10.23 10.44 1.31 4.09
8 L 20.00 0.66 21.50 0.39 13.00 1.68 2.54 4.26
9 R 35.71 46.30 53.57 9.17 15.71 2.49 18.60 3.68
10 R 37.86 1.98 44.17 1.86 29.17 7.47 3.77 4.02
11 R 38.03 1.93 42.25 5.30 23.94 0.64 3.00 8.27
These samples represent those where there was a signiﬁcant difference between the ACRanalysed and the ACRreference and/or discordant assessment with
respect to the lateralisation of aldosterone secretion. Abnormal lateralisation of aldosterone secretion was deﬁned as ACRO4. Reference samples were
deﬁned by the highest Cadrenal/Civc achieved in a given adrenal. Ipsilateral and contralateral reﬂects the relation to the analysed samples. Values are expressed
as the ratio of hormonal concentrations. AC represents the cortisol-corrected aldosterone concentration, deﬁned as a ratio of aldosterone (pmol/l) and cortisol
(nmol/l) in an adrenal sample. ACRanalysed represents the ratio of ACs based on the analysed and contralateral reference samples. ACRreference represents the
ratio of ACsreference of both adrenals in a given individual. Cadrenal/Civc represents the ratio of cortisol concentrations in the adrenal vein and in the inferior vena
cava. L and R represent left and right adrenal gland.
Table 5 The agreement between the analysed and reference samples in the detection of lateralisation of aldosterone secretion depending
upon different ACR cut-offs.
ACR cut-off
Cadrenal/Civc1.1–1.99
(%) (nZ44)
Cadrenal/Civc2–2.99
(%) (nZ25)
Cadrenal/Civc3–4.99
(%) (nZ25)
Cadrenal/Civc5–9.99
(%) (nZ20)
Cadrenal/CivcR10
(%) (nZ111)
O3 3 66 04 49 0 9 2
O4 3 95 27 28 5 9 4
O5 4 53 67 69 0 9 4
ACR represents the ratio of ACs from both adrenals, deﬁned as: ACdominant adrenal/ACnon-dominant adrenal. AC represents the cortisol-corrected aldosterone
concentration, deﬁned as a ratio of the aldosterone and cortisol concentrations in an adrenal sample. Cadrenal/Civc represents the ratio of the cortisol
concentrations in the adrenal vein and in the inferior vena cava. n denotes the number of analysed samples.
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observed in samples with Cadrenal/Civc1.1–1.99. The
inherent imprecision of laboratory measurements
might be ampliﬁed when assessing the lateralisation
of aldosterone secretion since ACR is derived from four
estimations of hormonal concentrations. Another
potential source of laboratory-related error lies in
the need to dilute samples when the hormonal
concentrations exceed the upper detection limit of
the assay used.
Thirdly, superselective adrenal sampling can occur in
adrenals with aldosterone-producing adenomas. When
the blood is not drawn from the principal adrenal vein
that drains the entire gland, but is instead drawn from
one if its branches (or an accessory adrenal vein) that
selectively drains an adenoma or unaffected adrenal
tissue, discrepancies in AC can be noted among high
Cadrenal/Civc samples taken from one adrenal. According
to our experience, this phenomenon is probably rare.
One possible example of superselective sampling is
shown in Table 4 (sample 9). The data describes a
patient with a right-sided Conn’s adenoma that was
conﬁrmed by marked clinical improvement after
surgery. In the analysed sample, there was a markedly
higher cortisol-corrected AC as compared with the
reference sample containing a higher concentration of
cortisol. This ﬁnding suggests that the analysed sample
was taken from the branch of the adrenal vein that
predominantly drained the aldosterone-producing
adenoma.
Fourthly, we cannot deﬁnitely exclude small ﬂuctu-
ations in hormonal concentrations during sequential
adrenal sampling despite the fact that all AVS
procedures were performed under highly supraphysio-
logic cosyntrophin infusion.
The main limitations of this study are the retro-
spective design and the fact that our results are related
uniquely to the AVS procedures performed under
cosyntrophin infusion. It is not clear to what extent
our data are applicable to the AVS protocols that do not
use adrenal stimulation.
To the best of our knowledge, similar data have not
previously been published. There are only a limited
number of reports that assess the various AVS
interpretation criteria with respect to the clinical effect
after unilateral adrenalectomy. In 2001, Rossi described
that Cadrenal/CivcR1.1 is an optimal cut-off for selective
adrenal sampling (14); however, this report was based
on AVS procedures performed without adrenal stimu-
lation by cosyntrophin. In fact, in this study, Cadrenal/
CivcR2 was the highest evaluated cut-off value to
identify selective adrenal samples. Moreover, the
method for estimating the optimal cut-off was diame-
tricallydifferent from the designs of our analysis. We are
not able to compare their ﬁndings with our results. In
2008, the same group described increased selectivity of
adrenal sampling when performed with cosyntrophin
infusion (17); however, no incremental diagnostic value
was observed in Cadrenal/Civc cut-off R2, which
contrasts to our observations. A recent retrospective
analysis by Kline et al. (10) described the discrepancies
among various criteria for the interpretation of AVS
results, and raised doubts about the validity of
AVS; however, it is important to note that Cadrenal/Civc-
R5 was achieved in only 40% of the evaluated AVSs in
this report.
Contrary to previously mentioned reports, neither the
optimal lateralisation index (ACR) nor the clinical
outcome of patients after adrenalectomy was assessed
in our analysis. The only aim of our study was to
evaluate the quality and consistency of information
regarding secretion of adrenal hormones obtained from
separate adrenal samples with different cortisol concen-
trations taken during one session. Nevertheless, we
consider our data very important for routine clinical
practices. These data show that adrenal samples are
acceptable for clinical decision making when they are
characterised by Cadrenal/CivcR5. The AVS results might
be better when multiple samples with Cadrenal/CivcR10
are obtained from both adrenal glands.
Conclusion
Our study clearly demonstrates that AVS provides
consistent information when adrenal samples with
high cortisol concentrations are used for the interpre-
tation of the data.
Declaration of interest
There are no pending conﬂicts of interest.
Funding
This work was supported by research projects MSM0021620817 and
MZO00179906.
References
1 Stowasser M, Klemm SA, Tunny TJ, Storie WJ, Rutherford JC &
Gordon RD. Response to unilateral adrenalectomy for aldosterone-
producing adenoma: effect of potassium levels and angiotensin
responsiveness. Clinical and Experimental Pharmacology and
Physiology 1994 21 319–322.
2 Young WF. Primary aldosteronism: renaissance of a syndrome.
Clinical Endocrinology 2007 66 607–618.
3 Weinberger MH, Grim CE, Holliﬁeld JW, Kem DC, Ganguly A,
Kramer NJ, Yune HY, Wellman H & Donohue JP. Primary
aldosteronism: diagnosis, localization, and treatment. Annals of
Internal Medicine 1979 90 386–395.
4 Doppman JL, Gill JR Jr, Miller DL, Chang R, Gupta R, Friedman TC,
Choyke PL, Feuerstein IM, Dwyer AJ, Jicha DL, Walther MM,
Norton JA & Linehan WM. Distinction between hyperaldosteron-
ism due to bilateral hyperplasia and unilateral aldosteronoma:
reliability of CT. Radiology 1992 184 677–682.
106 J Ceral and others EUROPEAN JOURNAL OF ENDOCRINOLOGY (2010) 162
www.eje-online.org5 Mulatero P, Stowasser M, Loh KC, Fardella CE, Gordon RD,
Mosso L, Gomez-Sanchez CE, Veglio F & Young WF. Increased
diagnosis of primary aldosteronism, including surgically correct-
able forms, in centers from ﬁve continents. Journal of Clinical
Endocrinology and Metabolism 2004 89 1045–1050.
6 Magill SB, Raff H, Shaker JL, Brickner RC, Knechtges TE, Kehoe ME
& Findling JW. Comparison of adrenal vein sampling and
computed tomography in the differentiation of primary aldoster-
onism. Journal of Clinical Endocrinology and Metabolism 2001 86
1066–1071.
7 Espiner EA, Ross DG, Yandle TG, Richards AM & Hunt PJ.
Predicting surgically remedial primary aldosteronism: role of
adrenal scanning, posture testing, and adrenal vein sampling.
Journal of Clinical Endocrinology and Metabolism 2003 88
3637–3644.
8 Phillips JL, Walther MM, Pezzullo JC, Rayford W, Choyke PL,
Berman AA, Linehan WM, Doppman JL & Gill JR. Predictive value
ofpreoperative tests in discriminatingbilateraladrenalhyperplasia
from an aldosterone-producing adrenal adenoma. Journal of
Clinical Endocrinology and Metabolism 2000 85 4526–4533.
9 Hirohara D, Nomura K, Okamoto T, Ujihara M & Takano K.
Performance of the basal aldosterone to renin ratio and of the
renin stimulation test by furosemide and upright posture in
screening for aldosterone-producing adenoma in low renin
hypertensives. Journal of Clinical Endocrinology and Metabolism
2001 86 4292–4298.
10 Kline GA, Harvey A, Jones C, Hill MH, So B, Scott-Douglas N &
Pasieka JL. Adrenal vein sampling may not be a gold-standard
diagnostic test in primary aldosteronism: ﬁnal diagnosis depends
upon which interpretation rule is used: variable interpretation of
adrenal vein sampling. International Urology and Nephrology 2008
40 1035–1043.
11 Funder JW, Carey RM, Fardella C, Gomez-Sanchez CE, Mantero F,
Stowasser M, Young WF Jr & Montori VM. Case detection,
diagnosis, and treatment of patients with primary aldosteronism:
an endocrine society clinical practice guideline. Journal of Clinical
Endocrinology and Metabolism 2008 93 3266–3281.
12 Mulatero P, Bertello C, Rossato D, Mengozzi G, Milan A, Garrone C,
Giraudo G, Passarino G, Garabello D, Verhovez A, Rabbia F &
Veglio F. Roles of clinical criteria, computed tomography scan, and
adrenal vein sampling in differential diagnosis of primary
aldosteronism subtypes. Journal of Clinical Endocrinology and
Metabolism 2008 93 1366–1371.
13 Young WF, Stanson AW, Thompson GB, Grant CS, Farley DR &
van Heerden JA. Role for adrenal venous sampling in primary
aldosteronism. Surgery 2004 136 1227–1235.
14 Rossi GP, Sacchetto A, Chiesura-Corona M, De Toni R, Gallina M,
Feltrin GP & Pessina AC. Identiﬁcation of the etiology of primary
aldosteronism with adrenal vein sampling in patients with
equivocal computed tomography and magnetic resonance ﬁnd-
ings: results in 104 consecutive cases. Journal of Clinical
Endocrinology and Metabolism 2001 86 1083–1090.
15 Stowasser M, Gordon RD, Rutherford JC, Nikwan NZ, Daunt N &
Slater GJ. Diagnosis and management of primary aldosteronism.
Journal of Renin-Angiotensin-Aldosterone System 2001 2 156–169.
16 Young WF & Stanson AW. What are the keys to successful adrenal
venous sampling (AVS) in patients with primary aldosteronism?
Clinical Endocrinology 2009 70 14–17.
17 Rossi GP, Pitter G, Bernante P, Motta R, Feltrin G & Miotto D.
Adrenal vein sampling for primary aldosteronism: the assessment
of selectivity and lateralization of aldosterone excess baseline and
after adrenocorticotropic hormone (ACTH) stimulation. Journal of
Hypertension 2008 26 989–997.
Received 18 June 2009
Accepted 12 July 2009
Adrenal venous sampling 107 EUROPEAN JOURNAL OF ENDOCRINOLOGY (2010) 162
www.eje-online.org